Application of therapeutic insonation to malignant glioma cells and facilitation by echo-contrast microbubbles of levovist

Anticancer Research

Volumn 29, Issue 1, 2009, Pages 235-242

  Manome, Yoshinobu ^a   Furuhata, Hiroshi ^a   Hashimoto, Akifumi ^a   Funamizu, Naotake ^a   Suzuki, Rie ^a   Ishizawa, Sho ^a   Akiyama, Nobutake ^a   Kobayashi, Toshiaki ^b   Watanabe, Michiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

Central nervous system; Echo contrast agent; Malignant glioma; Microbubbles; Ultrasound

Indexed keywords

SHU 508;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; GLIOMA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN CELL; INTRACRANIAL INSONATION; MICROBUBBLE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RAT; STEREOTACTIC TREATMENT; TREATMENT OUTCOME; ULTRASOUND THERAPY; ULTRASOUND TRANSDUCER;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CONTRAST MEDIA; FEMALE; GLIOMA; HUMANS; MICROBUBBLES; POLYSACCHARIDES; RATS; RATS, INBRED F344; SONICATION; ULTRASONIC THERAPY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 61449148692     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Manome Y, Nakamura M, Ohno T and Furuhata H: Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo. Hum Gene Ther 11: 1521-1528, 2000.
2. Manome Y, Nakayama N, Nakayama K and Furuhata H: Insonation facilitates plasmid DNA transfection into the central nervous system and microbubbles enhance the effect. Ultrasound Med Biol 31: 693-702, 2005.
3. Unger EC, Hersh E, Vannan M and McCreery T: Gene delivery using ultrasound contrast agents. Echocardiography 18: 355-361, 2001.
4. Unger EC, Hersh E, Vannan M, Matsunaga TO and McCreery T: Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 44: 45-54, 2001.
5. Luo W, Zhou X, Tian X, Ren, X, Zheng M, Gu K and He G: Enhancement of ultrasound contrast agent in high-intensity focused ultrasound ablation. Adv Ther 23: 861-868, 2006.
6. Kudo N, Miyaoka T, Okada K, Yamamoto K and Niwa K: Study on mechanisms of cell damage caused by microbubbles exposed to ultrasound. IEEE Ultrasonics Symp Proc, pp. 1351-1354, 2002.
7. Coussios CC, Farny CH, Haar GT and Roy RA: Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU). Int J Hyperthermia 23: 105-120, 2007.
8. Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M and Helenon O: Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 11: 1316-1328, 2001.
9. Marmottant P and Hilgenfeldt S: Controlled vesicle deformation and lysis by single oscillating bubbles: Nature 423: 153-156, 2003.
10. Bull JL: The application of microbubbles for targeted drug delivery. Expert Opin Drug Deliv 4: 475-493, 2007.
11. Postema M and Gilja OH: Ultrasound-directed drug delivery. Curr Pharm Biotechnol 8: 355-361, 2007.
12. Van Wamel A, Kooiman K and De Jong N: Ultrasound contrast agents pushing drug delivery: high speed optical observations. J Acoust Soc Am 123: 3215, 2008.
13. Tachibana K and Tachibana S: The use of ultrasound for drug delivery: Echocardiography 18: 323-328, 2001.
14. Ishibashi T, Akiyama M, Onoue H, Abe T and Furuhata H: Can transcranial ultrasonication increase recanalization flow with tissue plasminogen activator? Stroke 33: 1399-1404, 2002.
15. Saguchi T, Onoue H, Urashima M, Ishibashi T, Abe T and Furuhata H: Effective and safe conditions of low-frequency transcranial ultrasonic thrombolysis for acute ischemic stroke: neurologic and histologic evaluation in a rat middle cerebral artery stroke model. Stroke 39: 1007-1011, 2008.
16. Peril LB Jr, Kondo T, Zhao QL, Ogawa R, Tachibana K, Kudo N, Fujimoto S and Nakamura S: Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 29: 331-337, 2003.
17. Manome Y, Saeki N, Yoshinaga H, Watanabe M and Mizuno S: A culture device demonstrates that hydrostatic pressure increases mRNA of RGS5 in neuroblastoma and CHC1-L in lymphocytic cells. Cells Tissues Organs 174: 155-161, 2003.
18. Parr MJ, Manome Y, Tanaka T, Wen P, Kufe DW, Kaelin WG, Jr., and Fine HA: Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat Med 3: 1145-1149, 1997.
19. Kobayashi N, Allen N, Clendenon NR and Ko LW: An improved rat brain-tumor model. J Neurosurg 53: 808-815, 1980.
20. Manome Y, Watanabe M, Futaki K, Ishiguro H, Iwagami S, Noda K, Dobashi H, Ochiai Y, Ohara Y, Sanuki K, Kunieda T and Ohno T: Development of a syngenic brain-tumor model resistant to chloroethyl-nitrosourea using a methylguanine DNA methyltransferase cDNA. Anticancer Res 19: 5313-5318, 1999.
21. Manome Y, Watanabe M, Abe T, Tomita M, Watanabe S, Yokokawa Y, Takahashi Y, Ishii K, Kimura A, Murakami M Nagata M, Shibata T, Nakamura M, Tanigawa N and Ohno T: Transduction of thyrnidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor. Anticancer Res 21: 2265-2272, 2001.
22. Ohgaki H and Kleihues P: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64: 479-489, 2005.
23. Manome Y, Kobayashi T, Mori M, Suzuki R, Funamizu N, Akiyama N, Inoue S, Tabata Y and Watanabe M: Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet. Anticancer Res 26: 3317-3326, 2006.
24. Manome Y, Kunieda T, Wen PY, Koga T, Kufe DW and Ohno T: Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine. Hum Gene Ther 9: 1409-1417, 1998.
25. Tachibana K, Uchida T, Ogawa K, Yamashita N and Tamura K: Induction of cell-membrane porosity by ultrasound. Lancet 353: 1409, 1999.
26. Pampaloni F, Reynaud EG and Stelzer EH: The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8: 839-845, 2007.
27. Manome Y, Wen PY, Dong Y, Tanaka T, Mitchell BS, Kufe DW and Fine HA: Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat Med 2: 567-573, 1996.